Cabaletta Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cabaletta Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2018 to Q3 2024.
  • Cabaletta Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$30.6M, a 86.2% decline year-over-year.
  • Cabaletta Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$104M, a 66.7% decline year-over-year.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$67.7M, a 27.7% decline from 2022.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$53M, a 14.4% decline from 2021.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$46.3M, a 38.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$104M -$30.6M -$14.2M -86.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$90M -$27.6M -$13.1M -90.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$76.9M -$25M -$9.19M -58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$67.7M -$20.9M -$5.19M -33.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$62.5M -$16.4M -$5.02M -43.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$57.5M -$14.5M -$1.58M -12.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$55.9M -$15.9M -$2.91M -22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$53M -$15.7M -$1.8M -13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$51.2M -$11.4M +$133K +1.15% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$51.3M -$12.9M -$1.77M -15.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$49.5M -$12.9M -$3.24M -33.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$46.3M -$13.9M -$4.58M -49.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$41.7M -$11.6M -$3.17M -37.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$38.5M -$11.1M -$2.99M -36.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$35.6M -$9.7M -$2.22M -29.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$33.3M -$9.31M -$3.91M -72.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$29.4M -$8.39M -$3.74M -80.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$25.7M -$8.15M -$4.79M -143% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-01
Q1 2020 -$20.9M -$7.49M -$3.95M -112% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-01
Q4 2019 -$16.9M -$5.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$4.65M +$4.63M +49.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$3.36M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$3.53M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q3 2018 -$9.28M Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.